Feature

Cardiol Therapeutics Advancing Life-Changing Therapies for Heart Disease, Showing Potential to Reverse Inflammation-Driven Structural Damage

Cardiol Therapeutics (NASDAQ: CRDL; TSX: CRDL) is emerging as a leader in the development of anti-inflammatory and anti-fibrotic medicines designed to counteract the fundamental biological processes that drive...

December 2, 2025

Feature

Trevi reinventing chronic cough treatment with a dual-action approach to hypersensitivity

Trevi Therapeutics (NASDAQ: TRVI) is advancing a fundamentally different approach to the treatment of chronic cough—a high unmet need that significantly affects the quality of life for millions of Americans.

November 25, 2025

Feature

Experity placing human connection at the center of AI-driven urgent care

Closely held Experity Health is shaping the future of healthcare by embedding AI into urgent care hubs across the U.S. to improve patient access, speed clinical visits, and elevate care quality.

November 11, 2025

Feature

QT Imaging redefining breast health diagnostics with advanced ultrasound technologies, AI/ML, and quantitative imaging biomarkers

QT Imaging Holdings (OTCQB: QTIH) is reshaping the breast imaging landscape through a convergence of quantitative ultrasound, artificial intelligence (AI), and biomarker science—delivering a safer, more accessible...

November 4, 2025

NEWS

Stanford’s Dr. Ghanouni receives Cum Laude award for RSNA presentation on CAPTAIN trial of TULSA v robotic radical prostatectomy

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

Cardiol Therapeutics Advancing Life-Changing Therapies for Heart Disease, Showing Potential to Reverse Inflammation-Driven Structural Damage

Trevi reinventing chronic cough treatment with a dual-action approach to hypersensitivity

Experity placing human connection at the center of AI-driven urgent care

QT Imaging redefining breast health diagnostics with advanced ultrasound technologies, AI/ML, and quantitative imaging biomarkers

NEWS

Stanford’s Dr. Ghanouni receives Cum Laude award for RSNA presentation on CAPTAIN trial of TULSA v robotic radical prostatectomy

Ekso inks agreement to become exclusive U.S. distributor of MediTouch’s groundbreaking BalanceTutor rehab system

ADC announces updated data from trial of ZYNLONTA with glofitamab in r/r DLBCL

Black Diamond announces Phase 2 data for silevertinib in 1L NSCLC

Capricor reports positive topline results from Phase 3 study of Deramiocel in DMD

Actinium reports ATNM-400 data showing potent efficacy in TNBC

Cadrenal appoints Dr. Lee Golden to BOD

Dr. Mark Jaroszeski joins Aspire’s scientific team

BiomX reports update on trial of BX004 in CF

Just a few of the companies we’ve highlighted along the way

Subscribe